BioScreening News

  • Stem cells from human body fat used to deliver treatment for deadly glioblastoma in mice
    Johns Hopkins researchers say they have successfully used stem cells derived from human body fat to deliver biological treatments directly to the brains of mice with the most common and aggressive form of brain tumor, significantly extending their lives. In the mouse experiments, the Johns Hopkins investigators used mesenchymal stem...
  • NIH lays out plan to work exome data into clinical research
    Having seen the cost of exome sequencing tumble in recent years, the National Institutes of Health (NIH) has decided now is the time to jump-start its genomic medicine program. The upshot is more clinical research programs will soon have access to exome sequencing capabilities and NIH support with management of...
  • Positing Parkinson’s as an autoimmune disease
    Parkinson’s disease, like Alzheimer’s disease, is one of the leading neurodegenerative issues being targeted by the biopharmaceutical and life sciences industries today. It is the result of the death of neurons responsible for producing dopamine, which the Parkinson’s Disease Foundation describes as “A chemical messenger that regulates movement by assisting...
  • UCSF, Stanford and Johns Hopkins join FDA partnership to speed drug development
    At a time when Big Pharma is increasingly tapping academic institutions for expertise in informatics and data-driven computer models for drug discovery, the FDA has selected Johns Hopkins University, Stanford University and the University of California, San Francisco (UCSF) for a new initiative aimed at streamlining the drug development and...
  • Novavax, U. of Maryland report positive preclinical results for MERS vaccine
    With the arrival of Middle East respiratory syndrome coronavirus in the U.S. and a rising death toll in Saudi Arabia, a vaccine designed by Novavax ($NVAX) and the University of Maryland has shown promise in blocking the infection in animals. In a study published in Vaccine, researchers describe a novel...
  • Harvard’s bone marrow-on-a-chip could replace animal drug testing
    Scientists at Harvard’s Wyss Institute for Biologically Inspired Engineering have unveiled their newest tool for drug testing, dubbed “bone marrow-on-a-chip,” the first device of its kind that mimics the structure, functions and cellular make-up of bone marrow. Bone marrow is made up of complex tissue and has, up until now,...
  • Canada to set up cancer cloud computing facility
    Recognition of the insights hidden in genetic data and the difficulty in extracting them has prompted governments around the world to stump up cash for informatics projects. Canada is set to continue upping its investments in the field, with a cancer cloud computing facility the latest project to secure financial...
  • Possible treatment for kidney disease in lupus
    In the U.S. alone, more than 1.5 million people have lupus, a chronic autoimmune disease in which the immune system turns against itself, attacking a person’s healthy tissue, cells and organs. The symptoms can range from debilitating pain and fatigue to organ failure. Dr. Chandra Mohan, a biomedical engineer at...

Life Science Events

September 2014 October 2014 November 2014
Su Mo Tu We Th Fr Sa
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

eChemShop - Chemical Reagents and Equipment

TimTec Compound Libraries

1 DOW 16,805.41
+127.51 (0.76%)    
2 S&P 1,964.58
+13.76 (0.71%)    
3 NASDAQ 4,483.71
+30.92 (0.69%)